Surgery Partners to be taken private by Bon Secours affiliate in $5.7 billion deal
Key Points:
- Bain Capital, a minority shareholder owning 39% of Surgery Partners since 2017, will support the acquisition deal and maintain a significant ownership stake after closing.
- Remaining Surgery Partners shareholders will receive $23.50 per share, representing a 49% premium over the stock's last closing price.
- The deal, expected to close in Q1 2027, reflects a growing trend of healthcare operators expanding into outpatient surgery, following similar acquisitions like Ascension's purchase of AmSurg.
- Bon Secours Mercy Health will significantly expand its US presence by adding over 200 sites across 30 states and about 5,000 affiliated physicians through the acquisition.
- The transaction concludes a two-year strategic review period for Surgery Partners, with Bain Capital's previous bid to take the company private having been rejected last year.